. 2015 Feb 1;18(2):190–194. doi: 10.1089/jmf.2013.3139

Table 3.

Effect of Glycosaminoglycan on Liver Antioxidant Activity in Diabetic Mice (Mean±SD)

Group	SOD (U/mgprot)	GSH-Px (U/mgprot)	MDA (nmol/gprot)
Normal	349.13±49.50	869.60±93.87	13.18±3.67
Model control	196.33±64.64^**	437.91±58.64^**	25.41±4.61^**
Metformin hydrochloride	260.69±67.99	559.66±79.83	18.90±2.41^a
GAG-1	243.86±70.95	568.50±81.42^a	19.15±4.60^a
GAG-2	290.19±55.41^a	616.83±86.40^a	16.90±3.07^aa
GAG-3	317.69±52.97^aa	668.27±85.46^aa	15.79±2.96^aa

^{^**}

P<.01 as the model control group compared with normal group; ^aP<0.05, ^aaP<.01 as compared to the model control group.

SOD, superoxide dismutase.